Warsaw, Ind.-based Zimmer Biomet is acquiring CD Diagnostics, a Claymont, Del.-based company developing immunoassays and biomarker testing.
Here are five highlights:
1. The two companies partnered in 2012 to co-develop musculoskeletal healthcare diagnostics.
2. Under the initial partnership, Zimmer Biomet marketed the Synovasure Periprosthetic Joint Infection test.
3. CD Diagnostics creates diagnostics assays that help physicians make decisions which optimize patient care.
4. CD Diagnostics' laboratories have evaluated more than 40,000 samples.
5. The companies did not disclose financial details of the transaction.
"Our acquisition of CD Diagnostics cements our leadership and competitive advantage in musculoskeletal diagnostics, strengthens our Signature Solutions offering and advances our mission to provide comprehensive musculoskeletal healthcare," said Dan Williamson, group president of joint reconstruction, Zimmer Biomet.